“A Japanese university is to retract a study that touted the effectiveness of a blood pressure drug made by Swiss pharmaceutical giant Novartis because it was based on fabricated data. The move was the latest chapter in a growing scandal over allegations that bogus data were used in a string of Japanese university studies for the drug Valsartan which exaggerated its effectiveness in preventing strokes and angina. On Wednesday, Tokyo’s Jikei University School of Medicine said it would retract research that appeared in respected medical journal The Lancet six years ago.”
http://www.thelocal.ch/20130731/japanese-university-to-retract-novartis-drug-study
Related posts:
Marc Faber vs. Jim Rogers Conversation - CNBC 10/4/2012
Inflation Fuels Crises in Two Latin Nations
UK’s deficit ‘could be bigger than Greece's’
'My business accepts Bitcoins'
Indian yoga guru arrested for leading thousands in pro-taxation protest
Japan's nuclear crisis deepens, China expresses 'shock'
NBC: 'Bitcoin losing shine after hitting the spotlight'
Senators skip classified briefing on NSA snooping to catch flights home
‘Three Strikes of Injustice’
‘An attempt at vandalism’ ?
Fed links leveraged ETFs to 1987 crash
Russia warns UK against arming Syrian rebels
Bloomberg On Why Bitcoin Is Now Quoted On Its Terminals
Saudi Arabia Said to Ban Betting Against Its Currency
Government claims small gold miners won't be affected by mercury ban